JAMAand it’s related sister journals as part of theJAMA Networkhave adopted a new publishing policy, moving the journal not entirely into the open access space, but one that will give individuals access to JAMA articles on other sites.JAMA editors write:Beginning in 2023,JAMAand all of the journals

Healthcare Economist

16.12.2022

Can you emulate clinical trials with observational data? – Healthcare Economist

While randomized controlled trials (RCTs) are the gold standard of experimental research, there are some limitations. For instance, in some cases use of an RCT is not feasible (e.g., the sample size may be too small as in the case of rare disease), not ethical (e.g., if the previous standard of car

Healthcare Economist

17.12.2022

Links – Healthcare Economist

Reference pricing in Germany.End of life therapy after checkpoint inhibitors.Private equity and healthcare.medRxiv vs. peer-reviewed journals.Health benefits oflong-term care insurance.

Healthcare Economist

26.12.2022

2021 US National Health Expenditures – Healthcare Economist

A paper inHealth AffairsbyMartin, Hartman, Benson, Catlin, and The National Health Expenditure Accounts Team (2022)finds that national health expenditures (NHE) rose but declined as a share of gross domestic product (GDP).Health care spending in the US grew 2.7 percent to reach $4.3 trillion in 2021

home›Healthcare Economist

Healthcare Economist

Economy

Increased access to articles in JAMA – Healthcare Economist

Can you emulate clinical trials with observational data? – Healthcare Economist

Links – Healthcare Economist

2021 US National Health Expenditures – Healthcare Economist

home
›
Healthcare Economist